Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 1:01 pm Purchase | 2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX | Woodline Partners LP | 4,340,340 5.700% | 4,340,340 (New Position) | Filing History |
| 2024-11-14 1:00 pm Purchase | 2024-09-30 | 13G | Protara Therapeutics, Inc. TARA | Woodline Partners LP | 1,576,567 7.400% | 1,576,567 (New Position) | Filing History |
| 2024-11-14 1:00 pm Purchase | 2024-09-30 | 13G | Zevra Therapeutics, Inc. ZVRA | Woodline Partners LP | 4,048,653 7.700% | 4,048,653 (New Position) | Filing History |
| 2024-02-12 4:38 pm Purchase | 2023-12-31 | 13G | Vera Therapeutics, Inc. VERA | Woodline Partners LP | 1,140,632 2.200% | 1,140,632 (New Position) | Filing History |
| 2024-02-12 4:33 pm Sale | 2023-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI | Woodline Partners LP | 1,042 0.400% | -2,292 (-68.75%) | Filing History |
| 2024-02-12 4:32 pm Sale | 2023-12-31 | 13G | OPY Acquisition Corp. I OHAA | Woodline Partners LP | 0 0.000% | -200,000 (Position Closed) | Filing History |
| 2023-02-10 4:10 pm Sale | 2022-12-31 | 13G | Ascendant Digital Acquisition Corp. III ACDI | Woodline Partners LP | 1,286,000 4.300% | -626,500 (-32.76%) | Filing History |
| 2023-02-10 4:10 pm Purchase | 2022-12-31 | 13G | OPY Acquisition Corp. I OHAA | Woodline Partners LP | 200,000 8.100% | 200,000 (New Position) | Filing History |
| 2023-02-10 4:09 pm Unchanged | 2022-12-31 | 13G | Senti Biosciences, Inc. SNTI | Woodline Partners LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-02-10 4:08 pm Sale | 2022-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI | Woodline Partners LP | 3,333 9.700% | -13,167 (-79.80%) | Filing History |
| 2022-02-11 07:26 am Purchase | 2021-12-31 | 13G | Dynamics Special Purpose Corp. DYNS | Woodline Partners LP | 2,000,000 8.400% | 2,000,000 (New Position) | Filing History |
| 2022-02-11 07:25 am Purchase | 2021-12-31 | 13G | Ascendant Digital Acquisition Corp. III ACDI | Woodline Partners LP | 1,912,500 6.400% | 1,912,500 (New Position) | Filing History |
| 2022-02-11 07:23 am Purchase | 2021-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI | Woodline Partners LP | 16,500 8.600% | 16,500 (New Position) | Filing History |
| 2022-02-11 07:22 am Unchanged | 2021-12-31 | 13G | MarketWise, Inc. MKTW | Woodline Partners LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-11 07:20 am Purchase | 2021-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN | Woodline Partners LP | 685,273 4.800% | 685,273 (New Position) | Filing History |
| 2021-02-16 4:35 pm Purchase | 2020-12-31 | 13G | NOVUS THERAPEUTICS INC NVUS | Woodline Partners LP | 814,756 5.400% | 814,756 (New Position) | Filing History |
| 2021-02-16 4:34 pm Purchase | 2020-12-31 | 13G | ASCENDANT DIGITAL ACQUISITION ACND | Woodline Partners LP | 4,008,770 9.700% | 674,214 (+20.22%) | Filing History |